Zangouri VM, Akrami MM, Tahmasebi SM, Talei AM, Ghaeini Hesarooeih AM. Medullary breast carcinoma and invasive ductal carcinoma: a review study. Iran J Med Sci. 2018;43(4):365–71.

PubMed  PubMed Central  Google Scholar 

Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prevent: APJCP. 2004;5(1):24–7.

Google Scholar 

Brooks DLP, Schwab LP, Krutilina R, Parke DN, Sethuraman A, Hoogewijs D, et al. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol Cancer. 2016;15(1):1–19.

Article  Google Scholar 

Ho J-Y, Chang F-W, Huang FS, Liu J-M, Liu Y-P, Chen S-P, et al. Estrogen enhances the cell viability and motility of breast cancer cells through the ERα-ΔNp63-integrin β4 signaling pathway. PLoS One. 2016;11(2):e0148301.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Guo M, Chen J-H, Wang Z, Du X-F, Liu P-X, et al. Osteopontin knockdown inhibits αv, β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway. Cell Physiol Biochem. 2014;33(4):991–1002.

Article  PubMed  Google Scholar 

Wu Y, Liu X, Zhu Y, Qiao Y, Gao Y, Chen J, et al. Type IV collagen α 5 chain promotes luminal breast cancer progression through c-Myc-driven glycolysis. J Mol Cell Biol. 2022;14(10):mjac068.

Article  CAS  Google Scholar 

Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, et al. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells. Breast Cancer Res. 2015;17:1–18.

Article  Google Scholar 

Shu Y, Qin M, Song Y, Tang Q, Huang Y, Shen P, et al. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer. Immunology. 2020;160(4):345–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schaffner F, Ray AM, Dontenwill M. Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers (Basel). 2013;5(1):27–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou YT, Yu YQ, Yang H, Yang H, Huo YF, Huang Y, et al. Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF. Cancer Sci. 2022;113(7):2457–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindberg K, Ström A, Lock JG, Gustafsson JÅ, Haldosén LA, Helguero LA. Expression of estrogen receptor β increases integrin α1 and integrin β1 levels and enhances adhesion of breast cancer cells. J Cell Physiol. 2010;222(1):156–67.

Article  CAS  PubMed  Google Scholar 

Machado Brandão-Costa R, Helal-Neto E, Maia Vieira A, Barcellos-de-Souza P, Morgado-Diaz J, Barja-Fidalgo C. Extracellular matrix derived from high metastatic human breast cancer triggers epithelial-mesenchymal transition in epithelial breast cancer cells through αvβ3 integrin. Int J Mol Sci. 2020;21(8):2995.

Article  Google Scholar 

Havaki S, Kouloukoussa M, Amawi K, Drosos Y, Arvanitis LD, Goutas N, et al. Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell Int. 2007;7:16.

Article  PubMed  PubMed Central  Google Scholar 

Vora HH. Identification of extra cellular matrix (ECM) genes in triple negative breast cancer. Asian Pac J Cancer Biol. 2025;10(2):301–7.

Article  CAS  Google Scholar 

Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10(2):R26.

Article  PubMed  PubMed Central  Google Scholar 

Rashid MU, Muhammad N, Naeemi H, Khan FA, Hassan M, Faisal S, et al. Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study. Hereditary Cancer in Clinical Practice. 2019;17:27.

Article  PubMed  PubMed Central  Google Scholar 

Bao W, Strömblad S. Use of an immobilized monoclonal antibody to examine integrin α5β1 signaling independent of cell spreading. Biol Proced Online. 2002;4:81–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arias-Pinilla GA, Dalgleish AG, Mudan S, Bagwan I, Walker AJ, Modjtahedi H. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer. Sci Rep. 2020;10(1):537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chellaiah MA, Majumdar S, Aljohani H. Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro. PLoS One. 2018;13(9):e0204209.

Article  PubMed  PubMed Central  Google Scholar 

Marelli UK, Rechenmacher F, Sobahi TRA, Mas-Moruno C, Kessler H. Tumor targeting via integrin ligands. Front Oncol. 2013;3:222.

Article  PubMed  PubMed Central  Google Scholar 

Hill EE, Kim JK, Jung Y, Neeley CK, Pienta KJ, Taichman RS, et al. Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis. J Cell Biochem. 2018;119(10):8074–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan FA, Fang N, Zhang W, Ji S. The multifaceted role of Fragile X-Related Protein 1 (FXR1) in cellular processes: an updated review on cancer and clinical applications. Cell Death Dis. 2024;15(1):72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan FA, Ji X-Y, Ji S, Dong J. FXR1 modulates the expression of oncogenes and tumor suppressor genes associated with poor cancer prognosis. GPD. 2025. https://doi.org/10.36922/gpd.5068.

Article  Google Scholar 

Rashid MU, Khan FA, Muhammad N, Loya A, Hamann U. Prevalence of PALB2 germline mutations in early-onset and familial breast/ovarian cancer patients from Pakistan. Cancer Res Treat. 2019;51(3):992–1000.

Article  CAS  PubMed  Google Scholar 

Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research. 2002;30(1):207–10.

Maubant S, Tesson B, Maire V, Ye M, Rigaill G, Gentien D, et al. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells. PloS one. 2015;10(4):e0122333.

Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2 AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Molecular Med. 2016;8(5):527–49.

Clarke C, Madden SF, Doolan P, Aherne ST, Joyce H, O’driscoll L, et al. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis. 2013;34(10):2300–8.

Colak D, Nofal A, AlBakheet A, Nirmal M, Jeprel H, Eldali A, et al. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PloS one. 2013;8(5):e63204.

Ni IBP, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Emran NA, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Practice. 2010;206(4):223–8.

Brouwer-Visser J, Cheng W-Y, Bauer-Mehren A, Maisel D, Lechner K, Andersson E, et al. Regulatory T-cell genes drive altered immune microenvironment in adult solid cancers and allow for immune contextual patient subtyping. Cancer Epidemiol Bio Prevention. 2018;27(1):103–12.

Diamant I, Clarke DJ, Evangelista JE, Lingam N, Ma’ayan A. Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources. Nucleic Acids Res. 2025;53(D1):D1016–D28.

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W60.

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–d46.

Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222–D30.

Li R, Qu H, Wang S, Chater JM, Wang X, Cui Y, et al. CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer. Nucleic Acids Res. 2022;50(D1):D1139–D46.

Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–7.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.

Li Z, Zhang Y, Fang J, Xu Z, Zhang H, Mao M, et al. NcPath: a novel platform for visualization and enrichment analysis of human non-coding RNA and KEGG signaling pathways. Bioinformatics (Oxford, England). 2023;39(1).

Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. Ualcan: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yingtaweesittikul H, Wu J, Mongia A, Peres R, Ko K, Nagarajan N, et al. CREAMMIST: an integrative probabilistic database for cancer drug response prediction. Nucleic Acids Res. 2023;51(D1):D1242–D8.

Bao H, Huo Q, Yuan Q, Xu C. Fibronectin 1: a potential biomarker for ovarian cancer. Dis Markers. 2021;2021:1–11.

Article  Google Scholar 

wu y, Zhang C, Zou L, et al. FN1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Thyroid Carcinoma and Breast Invasive Carcinoma. Research Square; 2022.

Zhang X, Liu H, Zhang J, Wang Z, Yang S, Liu D, et al. Fibronectin-1: a predictive immunotherapy response biomarker for muscle invasive bladder cancer. Arch Esp Urol. 2023. https://doi.org/10.56434/j.arch.esp.urol.20237601.7.

Article  PubMed  Google Scholar 

Wang H, Zhang J, Li H, Yu H, Chen S, Liu S, et al. FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. Front Oncol. 2022;12:918719.

Article  CAS  PubMed  PubMed Central